On the current issued shares ZYB has an E/V of sub $3mill at the moment ,,, One customer signed and paying a licensing fee for the ZYB solution and we are looking at an E/V of $15 mill + imo
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
